1. Home
  2. ALT vs WOW Comparison

ALT vs WOW Comparison

Compare ALT & WOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • WOW
  • Stock Information
  • Founded
  • ALT 1997
  • WOW 2001
  • Country
  • ALT United States
  • WOW United States
  • Employees
  • ALT N/A
  • WOW N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • WOW Cable & Other Pay Television Services
  • Sector
  • ALT Health Care
  • WOW Telecommunications
  • Exchange
  • ALT Nasdaq
  • WOW Nasdaq
  • Market Cap
  • ALT 292.0M
  • WOW 285.5M
  • IPO Year
  • ALT N/A
  • WOW 2017
  • Fundamental
  • Price
  • ALT $3.83
  • WOW $5.09
  • Analyst Decision
  • ALT Strong Buy
  • WOW Hold
  • Analyst Count
  • ALT 6
  • WOW 2
  • Target Price
  • ALT $17.40
  • WOW $5.20
  • AVG Volume (30 Days)
  • ALT 3.0M
  • WOW 3.4M
  • Earning Date
  • ALT 08-12-2025
  • WOW 08-11-2025
  • Dividend Yield
  • ALT N/A
  • WOW N/A
  • EPS Growth
  • ALT N/A
  • WOW N/A
  • EPS
  • ALT N/A
  • WOW N/A
  • Revenue
  • ALT $20,000.00
  • WOW $604,800,000.00
  • Revenue This Year
  • ALT N/A
  • WOW N/A
  • Revenue Next Year
  • ALT $761,880.20
  • WOW N/A
  • P/E Ratio
  • ALT N/A
  • WOW N/A
  • Revenue Growth
  • ALT N/A
  • WOW N/A
  • 52 Week Low
  • ALT $2.90
  • WOW $3.06
  • 52 Week High
  • ALT $11.16
  • WOW $5.79
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • WOW 77.52
  • Support Level
  • ALT $3.35
  • WOW $5.06
  • Resistance Level
  • ALT $3.66
  • WOW $5.12
  • Average True Range (ATR)
  • ALT 0.19
  • WOW 0.03
  • MACD
  • ALT 0.07
  • WOW 0.03
  • Stochastic Oscillator
  • ALT 86.18
  • WOW 70.00

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About WOW WideOpenWest Inc.

WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.

Share on Social Networks: